We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$42.2M
AUM Growth
-$14.3M
Cap. Flow
-$17.4M
Cap. Flow %
-41.13%
Top 10 Hldgs %
21.94%
Holding
1,277
New
146
Increased
131
Reduced
218
Closed
593

Top Buys

Rank Stock Value
1
VBR icon
Vanguard Small-Cap Value ETF
VBR
+$601K
2
KNSL icon
Kinsale Capital Group
KNSL
+$335K
3
PXLW icon
Pixelworks
PXLW
+$273K
4
GM icon
General Motors
GM
+$255K
5
MITL
Mitel Networks Corporation
MITL
+$250K

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$623K
2
INTC icon
Intel
INTC
+$608K
3
BAC icon
Bank of America
BAC
+$558K
4
AAPL icon
Apple
AAPL
+$527K
5
FDC
First Data Corporation
FDC
+$384K

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Financials 9.93%
3 Healthcare 9.91%
4 Industrials 9.33%
5 Consumer Discretionary 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIXY icon
501
ProShares VIX Short-Term Futures ETF
VIXY
$211M
$6K 0.01%
3
– –
VNET
502
VNET Group
VNET
$2.05B
$6K 0.01%
+750
New +$5.46K
ZDGE icon
503
Zedge
ZDGE
$38.9M
$6K 0.01%
2,100
-1,000
-32% -$2.53K
SPWR
504
DELISTED
SunPower Corporation Common Stock
SPWR
$6K 0.01%
+1,145
New +$5.93K
MIXT
505
DELISTED
MIX TELEMATICS LIMITED
MIXT
$6K 0.01%
+500
New +$5.51K
AUY
506
DELISTED
Yamana Gold, Inc.
AUY
$6K 0.01%
1,850
– –
ALBO
507
DELISTED
Albireo Pharma Inc
ALBO
$6K 0.01%
+220
New +$5.58K
FLXN
508
DELISTED
Flexion Therapeutics, Inc.
FLXN
$6K 0.01%
+250
New +$6.12K
SNR
509
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$6K 0.01%
750
– –
PE
510
DELISTED
PARSLEY ENERGY INC
PE
$6K 0.01%
+200
New +$5.34K
PTLA
511
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$6K 0.01%
+125
New +$6.32K
CISN
512
DELISTED
Cision Ltd. Ordinary Share
CISN
$6K 0.01%
500
-250
-33% -$3.08K
EXAC
513
DELISTED
Exactech Inc
EXAC
$6K 0.01%
125
-400
-76% -$16.9K
ARCO icon
514
Arcos Dorados Holdings
ARCO
$1.73B
$5K 0.01%
514
– –
CVNA icon
515
Carvana
CVNA
$43.3B
$5K 0.01%
+1,250
New +$4.14K
GGN
516
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
$5K 0.01%
1,000
– –
GMED icon
517
Globus Medical
GMED
$10.4B
$5K 0.01%
125
-378
-75% -$13.2K
KTCC icon
518
Key Tronic
KTCC
$40.3M
$5K 0.01%
750
– –
MKL icon
519
Markel Group
MKL
$25B
$5K 0.01%
4
– –
MRVL icon
520
Marvell Technology
MRVL
$174B
$5K 0.01%
+250
New +$5.1K
NOV icon
521
NOV
NOV
$7.45B
$5K 0.01%
150
-156
-51% -$5.28K
NVCR icon
522
NovoCure
NVCR
$2.04B
$5K 0.01%
+250
New +$4.81K
QDEL icon
523
QuidelOrtho
QDEL
$1.09B
$5K 0.01%
+125
New +$5.11K
SEDG icon
524
SolarEdge
SEDG
$2.59B
$5K 0.01%
125
– –
SOHO
525
DELISTED
Sotherly Hotels
SOHO
$5K 0.01%
750
-6,000
-89% -$38.3K
19 20
21
22 23

Similar funds

PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
LA
Lakeside Advisors Seattle, Washington $150M AUM 14.73% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
GWA
Genesis Wealth Advisors Braintree, Massachusetts $150M AUM 15.35% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
E
Evansbrook Bolingbrook, Illinois $150M AUM

Thompson Davis & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Davis & Co held 1,277 positions worth $42.2M, down 25% from $56.5M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Thompson Davis & Co withdrew a net $17.4M in Q4 2017, closing 593 positions and reducing 218 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $365K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Thompson Davis & Co opened a new position in General Motors worth $241K.

  • Thompson Davis & Co's largest Q4 2017 buy was General Motors: 5,878 shares worth $241K.
  • Thompson Davis & Co added most to Vanguard Small-Cap Value ETF in Q4 2017, an estimated $601K increase.
  • Thompson Davis & Co's biggest Q4 2017 reduction was JPMorgan Chase, cutting an estimated $623K.
  • Thompson Davis & Co fully exited Antares Pharma, Inc. in Q4 2017, selling an estimated $365K.
  • Thompson Davis & Co's ten largest holdings make up 22% of its $42.2M portfolio in Q4 2017.
  • Thompson Davis & Co opened 146 new positions and closed 593 in Q4 2017.
  • Thompson Davis & Co's portfolio value fell 25% quarter-over-quarter to $42.2M.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.